banner add

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

from NYT > Health https://ift.tt/pTq5nkA
via IFTTT

No comments

UnitedHealth Group Reports Flat First-Quarter Earnings

One of the nation’s largest insurers, the company’s profits were higher than analysts’ expectations but still fell short of showing a signif...

Theme images by PLAINVIEW. Powered by Blogger.